TrialFrontiers in immunology2026

Fractional BNT162b2 boosters induce durable immune responses after non-mRNA priming in Mongolia: a randomised controlled trial.

Tsetsegsaikhan Batmunkh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.